期刊文献+

恶性脑胶质瘤术后嘧啶亚硝脲间质化疗同步放疗临床观察 被引量:3

Clinical observation on postoperative ACNU interstitial chemotherapy concurrent with radiotherapy for malignant gliomas
下载PDF
导出
摘要 目的 :探讨恶性脑胶质瘤术后嘧啶亚硝脲 (ACNU)间质化疗联合同步放疗的临床疗效。方法 :对 68例手术后恶性脑胶质瘤患者分成两组继续治疗 :A组 ( 38例 )行ACNU间质化疗联合同步放疗 ;B组 ( 30例 )行单纯放疗以作对照。所有病例均进行随访 ,近期效果用CT扫描比较。结果 :A组有效率 ( 86 8% )及 1、2、3a生存率 ( 92 1%、68 4%、5 0 0 % )明显高于B组 ( 2 6 6%及 5 0 0 %、16 6%、10 0 % ) (P <0 0 1)。两组均无明显毒副反应。结论 :恶性脑胶质瘤术后ACNU间质化疗联合同步放疗是一个安全有效的较佳选择治疗方案。 Objective To evaluate the effect of postoperative ACNU interstitial chemotherapy concurrent with radiotherapy for malignant gliomas.Methods Sixty eight patients with malignant gliomas who underwent surgical resections were classified into 2 groups.Group A (n=38) received ACNU interstitial chemotherapy concurrent with radiotherapy.Group B (n=30) received radiotherapy only as control group.The follow up of all 68 patients was made.CT scanning was used for comparing the effect.Results The effective rate (86.8%) and the 1,2,3 year's survival rates (92.1%,68.4%,50.0%) ingroup A were significantly higher than those of group B(26.6% and 50.0%,16.6%,10.0%)( P <0 01).Severe toxicity and adverse effects had not occurred. Conclusions Postoperative ACNU interstitial chemotherapy concurrent with radiotherapy for malignant gliomas is a safe,effective and alternative therapeutic plan.
出处 《河南诊断与治疗杂志》 2001年第4期196-197,共2页 Henan Journal of Diagnosis and Therapy
基金 河南省杰出青年科学基金资助
关键词 脑胶质瘤 间质化疗 外科手术 放射疗法 同步治疗 Glioma operation interstitial chemotherapy radiotherapy
  • 相关文献

参考文献3

二级参考文献6

共引文献47

同被引文献19

  • 1步星耀,赵红卫,雒建超,张永福,赵跃武,孔令非.显微手术后间质化疗联合增敏放疗治疗恶性脑胶质瘤[J].实用诊断与治疗杂志,2005,19(2):86-88. 被引量:6
  • 2步星耀,赵跃武,张永福,孔令非,雒建超,赵红卫.人脑恶性胶质瘤个体化综合治疗研究[J].医学研究通讯,2004,33(12):44-46. 被引量:3
  • 3Scutt A, Bertram P, Brautigarn M. The role of glu- cocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic line- age: positive and negative effects[ J ]. Calcif Tissue Int, 1996, 59(3) :154-162.
  • 4Grossman SA, Reinhard C. The intraeerebral distribution of BCNU delivered by surgically implanted biodegradable polymers[J]. J Neurosurg, 1992, 76(4) :640-647.
  • 5Campling B G, Pym J, Baker H M, et al. Chemosensi- tivity testing of small cell lung cancer using the MTr as- say [ J ]. Br J Cancer, 1991,65 ( 1 ) : 75-83.
  • 6Shrieve DC, Alexander E 3rd, Wen PY, et al. Com- parison of stereotaetic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma muhiforme [ J ]. Neurosurgery, 1995,36(2) :275-282.
  • 7Hochberg FH, Pruitt A. Assumptions in the radiothera- py of glioblastoma [ J ]. Neurology, 1980,30 ( 9 ) : 907- 911.
  • 8Bodell WJ, Bodell AP, Giannini DD. Levels and distri- bution of BCNU in GBM tumors following intratumoral injection of DTI -015 (BCNU -ethanol) [J]. Neuro Oncol, 2007, 9( 1 ) : 12-19.
  • 9Roth JG,Arthur RE. Glioblastoma multiforme:a clinical survey [J]. Neurosurg, 1960,19(7) :736.
  • 10Niyazi M,Siefert A,Schwarz SB,et al. Therapeutic options for recurrent malignant glioma [J ]. Radiother Oncol, 201 l, 98 ( 1 ) : 1-14.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部